Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$433K Hold
7,845
0.24% 80
2025
Q4
$385K Buy
7,845
+450
+6% +$21K 0.21% 85
2025
Q3
$319K Buy
7,395
+400
+6% +$15.6K 0.18% 104
2025
Q2
$269K Buy
6,995
+375
+6% +$14.3K 0.16% 126
2025
Q1
$256K Buy
6,620
+30
+0.5% +$1.1K 0.16% 124
2024
Q4
$223K Buy
6,590
+485
+8% +$17.5K 0.14% 156
2024
Q3
$250K Hold
6,105
0.15% 137
2024
Q2
$235K Hold
6,105
0.15% 134
2024
Q1
$262K Sell
6,105
-160
-3% -$6.6K 0.16% 121
2023
Q4
$232K Buy
+6,265
New +$225K 0.14% 133

Other funds holding GSK

Cetera Trust Company's GSK Position: Q1 2026 in Review

Cetera Trust Company held its GSK (GSK) position steady in Q1 2026 at 7,845 shares worth $433K. The position accounts for 0.24% of the portfolio, ranked #80.

Cetera Trust Company first reported a position in GSK in Q4 2023 and has held it in 10 quarters since. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Cetera Trust Company held 7,845 shares of GSK worth $433K as of Q1 2026.
  • Cetera Trust Company left its GSK share count unchanged in Q1 2026.
  • GSK made up 0.24% of Cetera Trust Company's portfolio in Q1 2026, its #80 holding.
  • Cetera Trust Company first reported a position in GSK in Q4 2023 and has held it in 10 quarters since.
  • 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Cetera Trust Company's 13F filing for Q1 2026, filed 8 May 2026.